Dr. Pol Vandenbroucke is the Vice President of Global Government Affairs at Shionogi. In this role, Pol directs the company's engagement with government bodies, policymakers, and regulatory agencies around the world, including the global fight against AMR. He has dedicated his career to Clinical Development, Medical Affairs, and Marketing worldwide. Previously, he held roles overseeing Medical Strategy at Pfizer Inc. and Medical Affairs for Pfizer’s Essential Health portfolio in North America. He led Clinical Development globally for Pfizer compounds and spearheaded initiatives targeting diseases prevalent in developing regions. Dr. Vandenbroucke sits on the boards of AFAR and BIO Ventures for Global Health and serves on advisory boards for several prominent institutions. He is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Medicine of the United Kingdom. As a prominent speaker on health and policy issues, he also teaches at King’s College and coordinates the Medical Affairs module at IFAPP Academy and King’s College London.
